Uvarigranol B exhibits significant antiproliferative activity against several cancer cell lines, making it a promising candidate for anticancer drug development. It has been studied for its ability to induce apoptosis in tumor cells through mitochondrial pathways. Additionally, it shows moderate anti-inflammatory effects by inhibiting key pro-inflammatory cytokines and enzymes such as TNF-α and COX-2. Its unique polycyclic structure also makes it valuable in synthetic organic chemistry as a template for designing bioactive molecules. Research is ongoing to explore its potential in treating neurodegenerative diseases due to its observed neuroprotective properties in preliminary in vitro models.